Nuclera
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $200.0Mattributed |
|---|---|
| Latest round | series-c, $75.0M, 2024-10-01attributed |
| Founded | 2013 |
| Headquarters | Cambridge, UK |
| Industry | bio |
| Stage | series-b+ |
| Website | nuclera.com |
Nuclera ships the eProtein Discovery System, a benchtop instrument using cell-free synthesis plus digital microfluidics to screen and express proteins, plus expression services for AI discovery. It serves drug-discovery and protein-engineering teams in pharma, especially groups working membrane proteins. Assay-ready proteins arrive in 48 hours via a three-step workflow.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-10-01 | series-c | $75.0M | undisclosed |
Detected tech stack
Cloudflare, Linkedin Ads, Linkedin Insight Tag, Google Tag Manager, Cloudflare Bot Management, NitroPack, WordPress, WP Engine, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series C, $75.0M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $200.0M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | nuclera.com, read 2026-05-07 |
| Description | self-reported | nuclera.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.